Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry
Erica J. Brenner(University of North Carolina Health Care), Michael D. Kappelman(University of North Carolina at Chapel Hill), Jean‐Frédéric Colombel(Mount Sinai Hospital), Gilaad G. Kaplan(University of Calgary), Ryan C. Ungaro(Feinstein Institute for Medical Research), Richard B. Gearry(Waitaki Biosciences (New Zealand)), James D. Lewis(University of Pennsylvania), Siew C. Ng(Chinese University of Hong Kong), Frank M. Ruemmele(Délégation Paris 5), Jean‐François Rahier(CHU Dinant Godinne UCL Namur), Flávio Steinwurz(Hospital Israelita Albert Einstein), Michele Kissous-Hunt(Mount Sinai Medical Center), Xian Zhang(University of North Carolina at Chapel Hill), Fox E. Underwood(University of Calgary), Walter Reinisch(Medical University of Vienna)
Cited by 692
Related Papers
Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes
|Science|2011|6.6k
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
|Nature Medicine|2013|4.4k